|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 January 2002, Vol. 99, No. 2, pp. 690-693
BRIEF REPORT
HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin
disease
Lea C. Harty,
Albert Y. Lin,
Alisa M. Goldstein,
Elaine S. Jaffe,
Mary Carrington,
Margaret A. Tucker, and
William S. Modi
From the Genetic Epidemiology Branch and the Laboratory
of Pathology, National Cancer Institute, Bethesda, MD; the Intramural
Research Support Program, SAIC Frederick, National Cancer
Institute-Frederick, MD; Stanford University School of Medicine, Palo
Alto, CA; and the Division of Hematology/Oncology, Santa Clara Valley
Medical Center, San Jose, CA.
The HLA region has long been implicated in sporadic and familial
Hodgkin disease (HD), with recent case-control studies suggesting that
HLA class II loci predispose to sporadic nodular sclerosis HD (NSHD).
To determine whether this predisposition extends to familial HD, HLA
class II loci (DRB1, DQA1, DQB1, DRB3, DRB4, and DRB5) and transporter
associated with antigen processing (TAP) loci (TAP1, TAP2) were
investigated in 100 members of 16 families with at least 2 confirmed
cases of HD. With the use of the transmission disequilibrium
test, evidence for linkage disequilibrium with familial HD and,
in particular, familial NSHD was obtained for the
DRB1*1501-DQA1*0102-DQB1*0602 haplotype, the TAP1 allele encoding Ile
at residue 333, and the DRB5-0101 allele. These 3 markers were in
linkage disequilibrium and may not represent independent susceptibility
regions. Use of a family-based approach excludes population
stratification as an explanation for these findings.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica,
July 1, 2007;
92(7):
960 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Friedman, N. S. Kadan-Lottick, J. Whitton, A. C. Mertens, Y. Yasui, Y. Liu, A. T. Meadows, L. L. Robison, and L. C. Strong
Increased Risk of Cancer among Siblings of Long-term Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2005;
14(8):
1922 - 1927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L R Goldin, M L McMaster, M Ter-Minassian, S Saddlemire, B Harmsen, G Lalonde, and M A Tucker
A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4
J. Med. Genet.,
July 1, 2005;
42(7):
595 - 601.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hjalgrim, S. Rasmussen, K. Rostgaard, N. M. Nielsen, N. Koch-Henriksen, L. Munksgaard, H. H. Storm, and M. Melbye
Familial Clustering of Hodgkin Lymphoma and Multiple Sclerosis
J Natl Cancer Inst,
May 19, 2004;
96(10):
780 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cozen, P. S. Gill, S. A. Ingles, R. Masood, O. Martinez-Maza, M. G. Cockburn, W. J. Gauderman, M. C. Pike, L. Bernstein, B. N. Nathwani, et al.
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
Blood,
April 15, 2004;
103(8):
3216 - 3221.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|